Sera Prognostics, Inc. (SERA) Financial Statements (2024 and earlier)

Company Profile

Business Address 2749 E. PARLEYS WAY
SALT LAKE CITY, UT 84109
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 8071 - Medical Laboratories (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2023
MRQ
12/31/2022
12/31/2021
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments82,704105,115
Cash and cash equivalents29,87858,932
Short-term investments52,82646,183
Receivables6,1133,143
Other undisclosed current assets1,3081,993
Total current assets:90,125110,251
Noncurrent Assets
Finance lease, right-of-use asset, after accumulated amortization 1,317 
Operating lease, right-of-use asset 1,707 
Property, plant and equipment  1,773
Long-term investments and receivables21,32934,848
Long-term investments21,32934,848
Other noncurrent assets1,816157
Other undisclosed noncurrent assets35 
Total noncurrent assets:26,20436,778
TOTAL ASSETS:116,329147,029
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities5,4735,082
Employee-related liabilities2,958
Accounts payable1,5481,197
Accrued liabilities3,925927
Deferred revenue9,0823,116
Debt464 
Deferred rent credit  139
Other undisclosed current liabilities51974
Total current liabilities:15,5388,411
Noncurrent Liabilities
Long-term debt and lease obligation626 
Finance lease, liability626 
Liabilities, other than long-term debt1,222 
Operating lease, liability1,222 
Other undisclosed noncurrent liabilities  54
Total noncurrent liabilities:1,84854
Total liabilities:17,3868,465
Equity
Equity, attributable to parent98,943138,564
Common stock33
Additional paid in capital310,575305,212
Accumulated other comprehensive loss(981)(183)
Accumulated deficit(210,654)(166,468)
Total equity:98,943138,564
TOTAL LIABILITIES AND EQUITY:116,329147,029

Income Statement (P&L) ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
Revenues26882
Gross profit:26882
Operating expenses(45,920)(35,477)
Operating loss:(45,652)(35,395)
Nonoperating income1,5271,132
Investment income, nonoperating1,071(48)
Interest and debt expense(61)1,050
Loss from continuing operations:(44,186)(33,213)
Loss before gain (loss) on sale of properties:(33,213)
Net loss:(44,186)(33,213)
Other undisclosed net loss attributable to parent  (1,796)
Net loss available to common stockholders, diluted:(44,186)(35,009)

Comprehensive Income ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
Net loss:(44,186)(33,213)
Other comprehensive income (loss)(798)(183)
Comprehensive loss:(44,984)(33,396)
Other undisclosed comprehensive loss, net of tax, attributable to parent  (1,796)
Comprehensive loss, net of tax, attributable to parent:(44,984)(35,192)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: